Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745627016 | Daclizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3745628014 | Product containing only daclizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4612981000052112 | läkemedel som endast innehåller daklizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclizumab only product in parenteral dose form | Is a | Product containing daclizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Daclizumab only product in parenteral dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Daclizumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Daclizumab only product in parenteral dose form | Is a | Product containing only daclizumab (medicinal product) | true | Inferred relationship | Some | ||
| Daclizumab only product in parenteral dose form | Has active ingredient | Daclizumab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR